Literature DB >> 3460687

Secondary chromosome aberrations in the acute leukemias.

S Heim, F Mitelman.   

Abstract

Information was retrieved from a computer-based data bank about additional chromosome aberrations in patients with acute lymphatic or nonlymphatic leukemia (ALL or ANLL) and one of the following primary rearrangements: In ALL t(9;22), t(11;14), t(1;19), t(4;11), t(8;14), and del(6q); in ANLL t(9;22), t(6;9), t(8;21), t(15;17), t(9;11), inv(16), and del(20q). The distribution of secondary changes was nonrandom. Chromosomes #1, #7, #8, and #9 were frequently involved in both disease groups, albeit with some pointed differences regarding the types of rearrangements making up the majority of aberrations. Chromosome #6 was clearly more affected in ALL, whereas, loss of a sex chromosome was largely restricted to ANLL patients. Differences between specific subtypes were detectable in both ALL and ANLL. Sex chromosome loss occurred almost exclusively in patients with t(8;21), who also tended to have del(9q) and/or trisomy 8. On the other hand, patients with t(15;17) often had del(7q) or monosomy 7, trisomy 8, and del (9q) as part of their karyotypes. None of the patients with inv(16) had del(9q). Instead, structural aberrations of chromosomes #7, #16, and #19 were fairly numerous in this subgroup, as was trisomy 8. Structural changes of #1, particularly translocations and duplications, were especially frequent in ALL patients with primary rearrangements t(8;14) or del(6q). In both ALL and ANLL, patients with t(9;22) had similar additional changes, often +8, -7, and/or +Ph. The findings indicate that the initial cytogenetic change is an important factor in determining the nature of subsequent chromosomal abnormalities developing in the malignant clone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460687     DOI: 10.1016/0165-4608(86)90025-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy.

Authors:  Anita Boyapati; Ming Yan; Luke F Peterson; Joseph R Biggs; Michelle M Le Beau; Dong-Er Zhang
Journal:  Blood       Date:  2006-12-29       Impact factor: 22.113

2.  Pediatric acute myeloid leukemia patients with i(17)(q10) mimicking acute promyelocytic leukemia: Two case reports.

Authors:  Hong-Xia Yan; Wei-Hua Zhang; Jin-Quan Wen; Yan-He Liu; Bao-Juan Zhang; A-Duo Ji
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

Review 3.  Cytogenetics in acute myeloid leukemia.

Authors:  Claudia Schoch; Torsten Haferlach
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 4.  Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.

Authors:  Luke F Peterson; Anita Boyapati; Eun-Young Ahn; Joseph R Biggs; Akiko Joo Okumura; Miao-Chia Lo; Ming Yan; Dong-Er Zhang
Journal:  Blood       Date:  2007-04-05       Impact factor: 22.113

5.  Application of log-linear model in inference on karyotypic evolution in chronic myelocytic leukemia.

Authors:  T Hashimoto; M Ohtaki; N Kamada; H Yamamoto; M Munaka
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

6.  Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.

Authors:  Yan Gao; Xiaohui Ni; Hua Guo; Zhe Su; Yi Ba; Zhongsheng Tong; Zhi Guo; Xin Yao; Xixi Chen; Jian Yin; Zhao Yan; Lin Guo; Ying Liu; Fan Bai; X Sunney Xie; Ning Zhang
Journal:  Genome Res       Date:  2017-05-09       Impact factor: 9.043

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.